Réaction #89835

ord-4d9bfd94fae54af5a79255f6e080a2cb

Équation de réaction

[Cl-]
chloride
CCN(CC)CC
Et3N
CC(C)(C)OC(=O)n1ncc2cc(Nc3nc(-c4cccc(N)c4)nc4ccccc34)ccc21
tert-butyl 5-(2-(3-aminophenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate
O=C(Cl)N1CCOCC1
morpholine-4-carbonyl chloride
O=C(Cl)N1CCOCC1
morpholine-4-carbonyl chloride
CCN(CC)CC
Et3N
CCN(CC)CC
Et3N
CC(C)(C)OC(=O)n1ncc2cc(Nc3nc(-c4cccc(NC(=O)N5CCOCC5)c4)nc4ccccc34)ccc21
tert-butyl 5-(2-(3-(morpholine-4-carboxamido)phenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate

Solvants

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    workup.ADDITIONwere added
  2. 2
    workup.ADDITIONwere added
  3. 3
    ConcentrationThe reaction was concentrated in vacuo
  4. 4
    Autrethe residue was purified by flash chromatography on silica (12:1 CH2Cl2:MeOH)

Mode opératoire

To a suspension of tert-butyl 5-(2-(3-aminophenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate (100 mg, 0.22 mmol) and morpholine-4-carbonyl chloride (51 μL, 0.44 mmol,) in CH2Cl2 (2 mL) was added Et3N (61 μL, 0.44 mmol) and catalytic amount of DMAP. The reaction mixture was stirred at RT for 2 h after which 2 equivalents each of morpholine-4-carbonyl chloride and Et3N were added. After 2 h of stirring another 2 equivalents of both the chloride and Et3N were added and continued to stir at ambient temperature for 16 hours. The reaction was concentrated in vacuo and the residue was purified by flash chromatography on silica (12:1 CH2Cl2:MeOH). The product tert-butyl 5-(2-(3-(morpholine-4-carboxamido)phenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate was isolated. (80 mg, 65%)

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US09440961B2uspto-grants-2016_09